drugset

drugset / Trial / NCT00000193

Neurobiology of Opioid Dependence: 2 - 2

NCT00000193 ↗

Phase 2 Withdrawn Yale University National Institute on Drug Abuse (NIDA) · collab

Double-blindTreatment

Summary

The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.

Timeline

Start: 1993-01
Primary completion: 1998-01
Completion: 1998-01

Publications

Background Neuropsychopharmacology, 1996; 14(3) pp 187-193. Neruopsychopharmacology 1996; 14(3), 187-193

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gamma hydroxybutyric	Unknown	—	—

Indications